ESC 365 - How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?

ESC Premium Access

How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?

Session: Biomarker-based approaches for improved atrial fibrillation management

Topic: Atrial Fibrillation (AF)

Speaker: Professor P. Kamphuisen (Hilversum, NL)

Sponsored by Roche

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Pieter Kamphuisen

Tergooi MC, Hilversum (Netherlands (The))

1 presentation

0 follower

2 more presentations in this session

Bleeding risk as one of major hurdles in stroke prevention therapy prescription.

Speaker: Professor C. Granger (Durham, US)

Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Access the full session

Biomarker-based approaches for improved atrial fibrillation management

Speakers: Professor P. Kamphuisen, Professor C. Granger, Associate Professor Z. Hijazi

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources